Učitavanje...

Cell and Gene Therapies for Refractory Epilepsy

Despite recent advances in the development of antiepileptic drugs, refractory epilepsy remains a major clinical problem affecting up to 35% of patients with partial epilepsy. Currently, there are few therapies that affect the underlying disease process. Therefore, novel therapeutic concepts are urge...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Detlev, Boison
Format: Artigo
Jezik:Inglês
Izdano: Bentham Science Publishers Ltd. 2007
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2435346/
https://ncbi.nlm.nih.gov/pubmed/18615179
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!